These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2635309)

  • 21. [Treatment of experimental silicosis with polyvinyl-pyridine-N-oxide].
    Bogdanskaia NI
    Gig Tr Prof Zabol; 1973 May; 17(5):22-5. PubMed ID: 4771393
    [No Abstract]   [Full Text] [Related]  

  • 22. Poly (2-vinylpyridine 1-oxide) in silicosis therapy: effective molecular weight.
    Hasirci VN; Holt PF
    Int Arch Occup Environ Health; 1977; 38(3):177-88. PubMed ID: 832913
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antisilicotic action and side effects of polypyridylethyl-methacrylate iodomethylate].
    Aronova GV; Borodulina SN; Katsnel'son BA; Velichkovskiĭ BT; Chupakhin ON
    Farmakol Toksikol; 1983; 46(4):89-93. PubMed ID: 6617843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exposure to silica and risk of ANCA-associated vasculitis.
    Bartůnková J; Pelclová D; Fenclová Z; Sedivá A; Lebedová J; Tesar V; Hladíková M; Klusácková P
    Am J Ind Med; 2006 Jul; 49(7):569-76. PubMed ID: 16691610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of beclomethasone dipropionate inhalation on eosinophilic bronchitis in patients with silicosis.
    Bando T; Fujimura M; Shinagawa S; Mizuhashi K; Noda Y; Ohta G; Hirone T; Matsuda T
    Arzneimittelforschung; 1997 Dec; 47(12):1370-4. PubMed ID: 9450166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of tetrandrine (TT) and polyvinylpyridine-N-oxide (PVNO) on gene expression of type I and type III collagens during experimental silicosis.
    Liu BC; He YX; Miao Q; Wang HH; You BR
    Biomed Environ Sci; 1994 Sep; 7(3):199-204. PubMed ID: 7848548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical studies on the elimination of hydroxyproline during treatment of silicosis in man with polyvinyl-pyridine-N-oxide (author's transl)].
    Schlipköter H; Grünspan M; Dehnen W; Mallner B
    Infection; 1974; 2(1):25-8. PubMed ID: 4598261
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of low-polymeric polyvinylpyridine-N-oxide on the activity of some pulmonary tissue enzymes in rats with experimental silicosis].
    Pavlova IV; Gel'fon IA; Veretinskaia AG; Mukhina ST; Fedorova VI
    Gig Tr Prof Zabol; 1975 Oct; (10):36-9. PubMed ID: 1213473
    [No Abstract]   [Full Text] [Related]  

  • 29. [Determination of serum polyvinylpyridine-N-oxide after intravenous administration in silicosis patients].
    Grünspan M; Antweiler H; Marcic I
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):101-13. PubMed ID: 5171408
    [No Abstract]   [Full Text] [Related]  

  • 30. [Combined treatment of experimental silicotuberculosis with poly-2-vinylpyridine-N-oxide and isoniazid].
    Frolova NN; Ozerova LV; Mordovskoĭ GG
    Probl Tuberk; 1975; (3):67-9. PubMed ID: 1135207
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antifibrous action of polyvinyl-pyridine-N-oxides in experimental silicosis].
    Bezrodnykh AA; Kasparov AA; Mazurov VI; Razvodovskiĭ EF; Kochetkova TA
    Gig Tr Prof Zabol; 1973 Dec; 17(12):20-4. PubMed ID: 4789533
    [No Abstract]   [Full Text] [Related]  

  • 32. [Inhibition of experimental silicosis by subcutaneous administration of polyvinylpyridine-N-oxide].
    SCHLIPKOETER HW; BROCKHAUS A
    Klin Wochenschr; 1961 Nov; 39():1182-9. PubMed ID: 14498575
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prophylactic action of polyvinylpyridine-N-oxide of different molecular weights on experimental silicosis].
    Bogdanskaia NI; Tolgskaia MS
    Gig Sanit; 1973 Apr; 38(4):102-4. PubMed ID: 4731236
    [No Abstract]   [Full Text] [Related]  

  • 34. NTP Toxicology and Carcinogenesis Studies of Ozone (CAS No. 10028-15-6) and Ozone/NNK (CAS No. 10028-15-6/ 64091-91-4) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Oct; 440():1-314. PubMed ID: 12595923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [MORPHOLOGIC, FUNCTIONAL AND BIOCHEMICAL STUDIES ON THE EFFECT OF POLYVINYLPYRIDINE-N-OXIDE ON EXPERIMENTAL SILICOSIS].
    BECK EG; ANTWEILER H; SCHILLER E
    Grundfragen Silikoseforsch; 1963; 6():233-44. PubMed ID: 14338733
    [No Abstract]   [Full Text] [Related]  

  • 36. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Change in the phospholipid status in experimental silicosis in rats and in exposure to polymeric preparations].
    Kupina LM
    Gig Tr Prof Zabol; 1978 Sep; (9):16-20. PubMed ID: 689453
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term test on rhesus monkeys for the PVNO therapy of anthracosilicosis.
    Weller W
    Inhaled Part; 1975 Sep; 4 Pt 1():379-87. PubMed ID: 829443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Behavior of the human liver during silicosis therapy using polyvinylpyridine-N-oxide (PVNO)].
    Haas P; Huber W
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):91-100. PubMed ID: 5171411
    [No Abstract]   [Full Text] [Related]  

  • 40. [Method of determination of polyvinylpyridine N-oxide in the urine and feces].
    Bolonova LN; Rodkina BS
    Lab Delo; 1977; (12):744-5. PubMed ID: 75327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.